Used as a chiral intermediate in the synthesis of pharmaceutical compounds, particularly in the development of fluorinated drug candidates. Its stereochemistry plays a key role in biological activity, making it valuable for creating enantioselective therapeutics. Commonly employed in oncology and CNS drug research due to the enhanced metabolic stability provided by the fluorine substituent. Also utilized in the preparation of kinase inhibitors and receptor modulators where the bromo group allows further functionalization via cross-coupling reactions.